Commonwealth Equity Services, LLC Marker Therapeutics, Inc. Transaction History

Commonwealth Equity Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.26 - $0.46 $2,096 - $3,709	-8,065 Reduced 39.41%	12,400 $4,000
Q4 2021 Jan 31, 2022	BUY	$0.95 - $1.72 $1,364 - $2,469	1,436 Added 7.55%	20,465 $19,000
Q3 2021 Oct 29, 2021	BUY	$1.68 - $2.88 $2,016 - $3,456	1,200 Added 6.73%	19,029 $32,000
Q2 2021 Aug 11, 2021	BUY	$1.88 - $3.56 $33,518 - $63,471	17,829 New	17,829 $49,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $269M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.